Efficacy of stress-response protease-deficient Salmonella enterica serovar Typhimurium as a candidate of live oral vaccine strain
Efficacy of stress-response protease-deficient Salmonella enterica serovar Typhimurium as a candidate of live oral vaccine strain
批准号:
15590398
负责人:
MATSUI Hidenori
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
鼠伤寒沙门氏菌(CS2022)经口服感染途径给药,具有免疫原性。在本研究中,CS2022在单次口服10^7CFU的沙门氏菌后,在小于102CFU的BALB/c小鼠的脾内持续停留了长达6周。在接种后4、6和13周,血清中鼠伤寒沙门氏菌脂多糖(LPS)特异性IgG2a显著升高。相反,在接种后6周和13周可检测到内毒素特异性IgG1。免疫后4周和6周,小鼠脾组织中干扰素-γ基因的表达显著增加。而IL-4mRNA的表达在接种后6周明显增加。结果,口服接种CS2022可以保护小鼠免受随后的强毒小鼠的皮下攻击。此外,通过皮下感染途径,接种后至少6周内,接种能够减少单核细胞增多性李斯特菌在肝脏中的定植。此外,免疫后2周、4周和6周免疫小鼠的腹腔巨噬细胞对单核细胞增生性李斯特菌和鼠伤寒沙门氏菌的细胞内杀伤活性均增强。这些结果表明,CS2022口服免疫可促进与巨噬细胞相关的保护性天然免疫,这种快速保护性免疫也可能足以在小鼠免疫后至少6周内消除沙门氏菌以外的某些细胞内病原体的定植。
英文摘要
The Lon protease-deficient Salmonella enterica serovar Typhimurium (CS2022) is immunogenic when given via the oral infection route in mice. In the present study, CS2022 continuously resided in the spleen of BALB/c mice with less than 10^2 CFU for up to 6 weeks after a single oral inoculation with 10^7 CFU of salmonellae. A significant increase in the serovar Typhimurium lipopolysaccharide (LPS)-specific IgG2a was detected in the serum at weeks 4, 6, and 13 after inoculation. In contrast, the LPS-specific IgG1 was detectable at weeks 6 and 13 after inoculation. The expression of IFN-γ mRNA in the spleens of these mice was significantly increased at weeks 4 and 6 after inoculation. In contrast, the expression of IL-4 mRNA was increased at week 6 after inoculation. As a result, oral inoculation with CS2022 protected mice against subsequent subcutaneous challenge with the virulent serovar Typhimurium. In addition, the inoculation was able to reduce the colonization of Listeria monocytogenes in the livers for at least 6 weeks after inoculation when it was administered via the subcutaneous infection route. Furthermore, peritoneal macrophages isolated from immunized mice at weeks 2, 4, and 6 after inoculation led to an increase in the intracellular killing activity against L.monocytogenes as well as against serovar Typhimurium. These findings suggest that oral immunization with CS2022 promoted the protective innate immunity associated with macrophages, and this rapid protective immunity might also be sufficient to eliminate the colonization of certain intracellular pathogens other than Salmonella for at least 6 weeks after immunization of mice.
期刊论文(102)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The DnaK/DnaJ chaperone machinery of Salmonella enterica serovar Typhimurium is essential for invasion of epithelial cells and survival in macrophages, leadin
鼠伤寒沙门氏菌的 DnaK/DnaJ 伴侣机制对于上皮细胞的侵袭和巨噬细胞的存活至关重要,
DOI:
--
发表时间:
2004
期刊:
Infect.Immun. 72・3
影响因子:
--
作者:
[A.Takaya, T.Tomoyasu, H.Matsui, T.Yamamoto]
通讯作者:
T.Yamamoto
Interaction of leptin with gastric myofibroblast transdifferentiation in Helicobacter pylori-infected Mongolian gerbils : effect of rebamipide.
瘦素与幽门螺杆菌感染的蒙古沙鼠胃肌成纤维细胞转分化的相互作用:瑞巴派特的作用。
DOI:
--
发表时间:
2003
期刊:
Alimentary Pharmacology and Therapeutics 18(Suppl.1)
影响因子:
--
作者:
[A.Takaya, T.Tomoyasu, H.Matsui, T.Yamamoto, M.Eguchi et al., M.Nakamura et al., M.Nakamura et al., M.Nakamura et al.]
通讯作者:
M.Nakamura et al.
M.Eguchi, K.Monden, N.Miwa.: "Role of MAPK phosphorylation in cytoprotection by pro-Vrtamin C aganst oxidative stress-induced injuries in cultured cardiomyoblasts and perfused rat heart"J.Cell.Biochem.. 90・2. 219-226 (2003)
M.Eguchi、K.Monden、N.Miwa.:“MAPK 磷酸化在 Vrtamin C 前体细胞保护中的作用,对抗培养的成肌细胞和灌注大鼠心脏中氧化应激诱导的损伤”J.Cell.Biochem.. 90・2。 219-226 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Cytoprotection against ischemia-induced DNA cleavages and cell injuries in the rat liver by pro-vitamine C via hydrolytic conversion into ascorbate.
维生素原 C 通过水解转化为抗坏血酸,对大鼠肝脏中缺血诱导的 DNA 裂解和细胞损伤产生细胞保护作用。
DOI:
--
发表时间:
2003
期刊:
Mol.Cell.Biochem. 252(1-2)
影响因子:
--
作者:
[A.Takaya, T.Tomoyasu, H.Matsui, T.Yamamoto, M.Eguchi et al.]
通讯作者:
M.Eguchi et al.
Mediators in Gastrointestinal Protection and Repair
胃肠道保护和修复的调节剂
DOI:
--
发表时间:
2004
期刊:
影响因子:
--
作者:
[M.Eguchi, T.Miyazaki, E.Masatsuji-Kato, T.Tsuzuki, T.Oribe, N.Miwa., M.Nakamura et al., M.Nakamura et al.]
通讯作者:
M.Nakamura et al.
共 37 条
Functional analysis of ROS signal regulator "RAM1" in plant defense
-
批准号:25850034
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2013
-
负责人:MATSUI Hidenori
-
依托单位:
Functional analysis of a novel phosphorylation regulator in MAMPs signaling
-
批准号:23780048
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.83万
-
财政年份:2011
-
负责人:MATSUI Hidenori
-
依托单位:
Identification of the virulence factors associated with Helicobacter heilmannii-induced gastric MALT lymphoma
-
批准号:21590491
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:MATSUI Hidenori
-
依托单位:
Induction of cellular immunity by oral inoculation of attenuated Salmonella as a live vaccine vector
-
批准号:13670288
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:2001
-
负责人:MATSUI Hidenori
-
依托单位:
国内基金
海外基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
-
批准号:31600836
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:杨俊华
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位:
胰腺癌MUC4抗原多表位嵌合DNA疫苗的设计和免疫研究
-
批准号:30500492
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:高文涛
-
依托单位: